Skip to main content
Cellular and Molecular Life Sciences: CMLS logoLink to Cellular and Molecular Life Sciences: CMLS
. 2007 Aug 11;64(21):2746–2762. doi: 10.1007/s00018-007-7164-1

Notch and cancer: a double-edged sword

U Koch 1, F Radtke 1,
PMCID: PMC11136344  PMID: 17687513

Abstract.

The highly conserved Notch signaling pathway plays pleiotropic roles during embryonic development and is important for the regulation of selfrenewing tissues. The physiological functions of this signaling cascade range from stem cell maintenance and influencing cell fate decisions of barely differentiated progenitor cells, to the induction of terminal differentiation processes, all of which have been found to be recapitulated in different forms of cancers. Although Notch signaling has mostly been associated with oncogenic and growth-promoting roles, depending on the tissue type it can also function as a tumor suppressor. Here we describe recent findings on Notch signaling in cancer and tumor angiogenesis, and highlight some of the therapeutic approaches that are currently being developed to interfere with tumor growth and progression.

Keywords. Notch signaling, oncogene, tumor suppressor, cancer, therapy

Footnotes

Received 2 April 2007; received after revision 29 June 2007; accepted 2 July 2007

Change history

3/21/2008

An Erratum to this paper has been published: 10.1007/s00018-008-8000-y


Articles from Cellular and Molecular Life Sciences: CMLS are provided here courtesy of Springer

RESOURCES